Document is current
Any future updates will be listed below
-
Authors
Lareau, Caleb A. https://orcid.org/0000-0003-4179-4807
Yin, Yajie https://orcid.org/0000-0002-2220-005X
Maurer, Katie https://orcid.org/0000-0002-4160-181X
Sandor, Katalin D. https://orcid.org/0000-0003-2892-4865
Daniel, Bence https://orcid.org/0000-0002-2410-8767
Yagnik, Garima
Peña, José https://orcid.org/0000-0002-9662-906X
Crawford, Jeremy Chase https://orcid.org/0000-0003-4096-6048
Spanjaart, Anne M. https://orcid.org/0000-0003-0167-6021
Gutierrez, Jacob C.
Haradhvala, Nicholas J. https://orcid.org/0000-0003-1113-3135
Riberdy, Janice M.
Abay, Tsion https://orcid.org/0009-0009-0024-2732
Stickels, Robert R. https://orcid.org/0000-0003-4326-4084
Verboon, Jeffrey M.
Liu, Vincent https://orcid.org/0000-0002-6790-6603
Buquicchio, Frank A.
Wang, Fangyi https://orcid.org/0009-0000-8310-3088
Southard, Jackson
Song, Ren
Li, Wenjing
Shrestha, Aastha
Parida, Laxmi https://orcid.org/0000-0002-7872-5074
Getz, Gad https://orcid.org/0000-0002-0936-0753
Maus, Marcela V. https://orcid.org/0000-0002-7578-0393
Li, Shuqiang https://orcid.org/0000-0001-9106-6141
Moore, Alison
Roberts, Zachary J.
Ludwig, Leif S.
Talleur, Aimee C. https://orcid.org/0000-0002-6558-6706
Thomas, Paul G. https://orcid.org/0000-0001-7955-0256
Dehghani, Houman
Pertel, Thomas
Kundaje, Anshul https://orcid.org/0000-0003-3084-2287
Gottschalk, Stephen https://orcid.org/0000-0003-3991-7468
Roth, Theodore L. https://orcid.org/0000-0002-3970-9573
Kersten, Marie J. https://orcid.org/0000-0002-8904-3802
Wu, Catherine J. https://orcid.org/0000-0002-3348-5054
Majzner, Robbie G. https://orcid.org/0000-0001-6969-8011
Satpathy, Ansuman T. https://orcid.org/0000-0002-5167-537X
- License Information
-
More Information
Article History
Received: 12 August 2022
Accepted: 3 October 2023
First Online: 8 November 2023
Competing interests
: A.T.S. is a founder of Immunai and Cartography Biosciences and receives research funding from Allogene Therapeutics and Merck Research Laboratories. C.A.L. and L.S.L. are consultants to Cartography Biosciences. N.J.H. is a consultant for Constellation Pharmaceuticals. C.J.W. holds equity in BioNTech Inc and receives research funding from Pharmacyclics. G.G. receives research funds from IBM and Pharmacyclics, and is a founder of, consultant for and holder of private equity in Scorpion Therapeutics. M.V.M. is an inventor on patents related to CAR T cell therapies held by the University of Pennsylvania (some licensed to Novartis), holds equity in TCR2, Century Therapeutics, Genocea, Oncternal and Neximmune, has served as a consultant for multiple companies involved in cell therapies, receives research support from KitePharma and Moderna, and serves on the Board of Directors of 2Seventy Bio. M.J.K. has received research funding from Kite, a Gilead Company, as well as honoraria from Kite, a Gilead Company, Novartis, Takeda, Miltenyi Biotec, BMS/Celgene, Beigene and Adicet Bio. S.G. is a co-inventor on patent applications in the fields of cell or gene therapy for cancer, a consultant for TESSA Therapeutics and a member of the Data and Safety Monitoring Board of Immatics, and has received honoraria from Tidal, Catamaran Bio, Sanofi and Novartis within the past 2 years. J.C.C. and P.G.T. are named on patent applications in the fields of T cell or gene therapy for cancer. G.Y., J.P., R.S., W.L., A.S., A.M., Z.J.R., T.P. and H.D. are employees and shareholders of Allogene Therapeutics. A.K. is a scientific cofounder of Ravel Biotechnology Inc., is on the scientific advisory board of PatchBio Inc., SerImmune Inc., AINovo Inc., TensorBio Inc. and OpenTargets, is a consultant with Illumina Inc. and owns shares in DeepGenomics Inc., Immunai Inc. and Freenome Inc. R.G.M. is a cofounder of and holds equity in Link Cell Therapies and CARGO Therapeutics, and is a consultant for Lyell Immunopharma, NKarta, Arovella Pharmaceuticals, Innervate Radiopharmaceuticals, Aptorum Group, Gadeta, FATE Therapeutics (Data and Safety Monitoring Board) and Waypoint Bio. All other authors declare no competing interests.
